172 related articles for article (PubMed ID: 18720195)
1. Liposome-mediated triggering of complement cascade.
Moghimi SM; Hamad I
J Liposome Res; 2008; 18(3):195-209. PubMed ID: 18720195
[TBL] [Abstract][Full Text] [Related]
2. Complement activation as a bioequivalence issue relevant to the development of generic liposomes and other nanoparticulate drugs.
Szebeni J; Storm G
Biochem Biophys Res Commun; 2015 Dec; 468(3):490-7. PubMed ID: 26182876
[TBL] [Abstract][Full Text] [Related]
3. Pseudo-anaphylaxis to Polyethylene Glycol (PEG)-Coated Liposomes: Roles of Anti-PEG IgM and Complement Activation in a Porcine Model of Human Infusion Reactions.
Kozma GT; Mészáros T; Vashegyi I; Fülöp T; Örfi E; Dézsi L; Rosivall L; Bavli Y; Urbanics R; Mollnes TE; Barenholz Y; Szebeni J
ACS Nano; 2019 Aug; 13(8):9315-9324. PubMed ID: 31348638
[TBL] [Abstract][Full Text] [Related]
4. Methylation of the phosphate oxygen moiety of phospholipid-methoxy(polyethylene glycol) conjugate prevents PEGylated liposome-mediated complement activation and anaphylatoxin production.
Moghimi SM; Hamad I; Andresen TL; Jørgensen K; Szebeni J
FASEB J; 2006 Dec; 20(14):2591-3. PubMed ID: 17065229
[TBL] [Abstract][Full Text] [Related]
5. The interaction of liposomes with the complement system.
Szebeni J
Crit Rev Ther Drug Carrier Syst; 1998; 15(1):57-88. PubMed ID: 9523086
[TBL] [Abstract][Full Text] [Related]
6. Complement: alive and kicking nanomedicines.
Andersen AJ; Hashemi SH; Andresen TL; Hunter AC; Moghimi SM
J Biomed Nanotechnol; 2009 Aug; 5(4):364-72. PubMed ID: 20055082
[TBL] [Abstract][Full Text] [Related]
7. Features of complement activation-related pseudoallergy to liposomes with different surface charge and PEGylation: comparison of the porcine and rat responses.
Dézsi L; Fülöp T; Mészáros T; Szénási G; Urbanics R; Vázsonyi C; Őrfi E; Rosivall L; Nemes R; Kok RJ; Metselaar JM; Storm G; Szebeni J
J Control Release; 2014 Dec; 195():2-10. PubMed ID: 25148822
[TBL] [Abstract][Full Text] [Related]
8. Liposome-induced pulmonary hypertension: properties and mechanism of a complement-mediated pseudoallergic reaction.
Szebeni J; Baranyi L; Savay S; Bodo M; Morse DS; Basta M; Stahl GL; Bünger R; Alving CR
Am J Physiol Heart Circ Physiol; 2000 Sep; 279(3):H1319-28. PubMed ID: 10993799
[TBL] [Abstract][Full Text] [Related]
9. Activation of complement by therapeutic liposomes and other lipid excipient-based therapeutic products: prediction and prevention.
Szebeni J; Muggia F; Gabizon A; Barenholz Y
Adv Drug Deliv Rev; 2011 Sep; 63(12):1020-30. PubMed ID: 21787819
[TBL] [Abstract][Full Text] [Related]
10. Surprising lack of liposome-induced complement activation by artificial 1,3-diamidophospholipids in vitro.
Bugna S; Buscema M; Matviykiv S; Urbanics R; Weinberger A; Meszaros T; Szebeni J; Zumbuehl A; Saxer T; Müller B
Nanomedicine; 2016 Apr; 12(3):845-849. PubMed ID: 26733261
[TBL] [Abstract][Full Text] [Related]
11. Hemodynamic changes induced by liposomes and liposome-encapsulated hemoglobin in pigs: a model for pseudoallergic cardiopulmonary reactions to liposomes. Role of complement and inhibition by soluble CR1 and anti-C5a antibody.
Szebeni J; Fontana JL; Wassef NM; Mongan PD; Morse DS; Dobbins DE; Stahl GL; Bünger R; Alving CR
Circulation; 1999 May; 99(17):2302-9. PubMed ID: 10226097
[TBL] [Abstract][Full Text] [Related]
12. Study of complement-mediated anaphylaxis in humans. The role of IgG subclasses (IgG1 and/or IgG4) in the complement-activating capacity of immune complexes.
Bergamaschini L; Santangelo T; Faricciotti A; Ciavarella N; Mannucci PM; Agostoni A
J Immunol; 1996 Feb; 156(3):1256-61. PubMed ID: 8558005
[TBL] [Abstract][Full Text] [Related]
13. Complement activation-related pseudoallergy: a new class of drug-induced acute immune toxicity.
Szebeni J
Toxicology; 2005 Dec; 216(2-3):106-21. PubMed ID: 16140450
[TBL] [Abstract][Full Text] [Related]
14. Activation of the human complement system by cholesterol-rich and PEGylated liposomes-modulation of cholesterol-rich liposome-mediated complement activation by elevated serum LDL and HDL levels.
Moein Moghimi S; Hamad I; Bünger R; Andresen TL; Jørgensen K; Hunter AC; Baranji L; Rosivall L; Szebeni J
J Liposome Res; 2006; 16(3):167-74. PubMed ID: 16952871
[TBL] [Abstract][Full Text] [Related]
15. Complement activation-related pseudoallergy caused by liposomes, micellar carriers of intravenous drugs, and radiocontrast agents.
Szebeni J
Crit Rev Ther Drug Carrier Syst; 2001; 18(6):567-606. PubMed ID: 11789676
[TBL] [Abstract][Full Text] [Related]
16. Animal models of complement-mediated hypersensitivity reactions to liposomes and other lipid-based nanoparticles.
Szebeni J; Alving CR; Rosivall L; Bünger R; Baranyi L; Bedöcs P; Tóth M; Barenholz Y
J Liposome Res; 2007; 17(2):107-17. PubMed ID: 17613700
[TBL] [Abstract][Full Text] [Related]
17. Monitoring Surface Reactions by Combined Western Blot-ELISA Analysis.
Lin Y; Irmscher S; Skerka C
Methods Mol Biol; 2019; 1834():75-83. PubMed ID: 30324437
[TBL] [Abstract][Full Text] [Related]
18. Complement activation-related cardiac anaphylaxis in pigs: role of C5a anaphylatoxin and adenosine in liposome-induced abnormalities in ECG and heart function.
Szebeni J; Baranyi L; Sávay S; Bodó M; Milosevits J; Alving CR; Bünger R
Am J Physiol Heart Circ Physiol; 2006 Mar; 290(3):H1050-8. PubMed ID: 16214844
[TBL] [Abstract][Full Text] [Related]
19. Effects of Bothrops atrox venom and two isolated toxins on the human complement system: Modulation of pathways and generation of anaphylatoxins.
Menaldo DL; Bernardes CP; Jacob-Ferreira AL; Nogueira-Santos CG; Casare-Ogasawara TM; Pereira-Crott LS; Sampaio SV
Mol Immunol; 2016 Dec; 80():91-100. PubMed ID: 27846429
[TBL] [Abstract][Full Text] [Related]
20. [The developoment of total complement activity assay based on complement-dependent immune liposome lysis].
Skopinskaia SN; Iarkov SP; Khramov EN; Antashev AV
Vestn Ross Akad Med Nauk; 2014; (3-4):24-30. PubMed ID: 25306592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
